These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2572499)

  • 41. Class I antigen presentation.
    Jelachich ML; Biddison WE
    Year Immunol; 1989; 4():41-58. PubMed ID: 2522701
    [No Abstract]   [Full Text] [Related]  

  • 42. T lymphocytes from human chimeras do recognize antigen in the context of allogeneic determinants of the major histocompatibility complex.
    Touraine JL; Roncarolo MG; Plotnicky H; Bachetta R; Spits H
    Immunol Lett; 1993 Dec; 39(1):9-12. PubMed ID: 7511565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: a study with transgenic mice.
    Kievits F; Wijffels J; Lokhorst W; Ivanyi P
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):617-20. PubMed ID: 2783490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The presentation of cell surface alloantigens to T cells.
    Owens T; Czitrom AA; Gascoigne NR; Crispe IN; Ratcliffe MJ; Lai PK; Mitchison NA
    Immunobiology; 1984 Dec; 168(3-5):189-201. PubMed ID: 6241598
    [No Abstract]   [Full Text] [Related]  

  • 45. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
    Zhou G; Ding ZC; Fu J; Levitsky HI
    J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-presentation: underlying mechanisms and role in immune surveillance.
    Rock KL; Shen L
    Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P; Serre K; Baillet M; Leserman L
    J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antigen organization regulates cluster formation and induction of cytotoxic T lymphocytes by helper T cell subsets.
    Stuhler G; Schlossman SF
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):622-7. PubMed ID: 9012834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antigen processing by macrophages: definition of the ligand recognized by T-inducer cells.
    Puri J; Abromson-Leeman S; Cantor H
    Eur J Immunol; 1985 Apr; 15(4):362-8. PubMed ID: 3157582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. B Cells Are the Dominant Antigen-Presenting Cells that Activate Naive CD4
    Hong S; Zhang Z; Liu H; Tian M; Zhu X; Zhang Z; Wang W; Zhou X; Zhang F; Ge Q; Zhu B; Tang H; Hua Z; Hou B
    Immunity; 2018 Oct; 49(4):695-708.e4. PubMed ID: 30291027
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T-cell responses to minor histocompatibility antigens.
    Lai PK; Waterfield JD; Gascoigne NR; Sharrock CE; Mitchison NA
    Immunology; 1982 Oct; 47(2):371-81. PubMed ID: 6214502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Killing of antigen-reactive B cells by class II-restricted, soluble antigen-specific CD8+ cytolytic T lymphocytes.
    Shinohara N; Watanabe M; Sachs DH; Hozumi N
    Nature; 1988 Dec; 336(6198):481-4. PubMed ID: 2973566
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel strategy for immunotherapy using antibody-coupled carriers to focus cytotoxic T helper cells.
    Ochi A; Worton KS; Woods G; Gravelle M; Kitagami K
    Eur J Immunol; 1987 Nov; 17(11):1645-8. PubMed ID: 2960548
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Adorini L; Ullrich SJ; Appella E; Fuchs S
    Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Macrophages as accessory cells for class I MHC-restricted immune responses.
    Debrick JE; Campbell PA; Staerz UD
    J Immunol; 1991 Nov; 147(9):2846-51. PubMed ID: 1833459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. T cell competition for the antigen-presenting cell as a model for immunodominance in the cytotoxic T lymphocyte response against minor histocompatibility antigens.
    Grufman P; Wolpert EZ; Sandberg JK; Kärre K
    Eur J Immunol; 1999 Jul; 29(7):2197-204. PubMed ID: 10427982
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of CD4 and CD8 T cells in viral infections.
    Koszinowski UH; Reddehase MJ; Jonjic S
    Curr Opin Immunol; 1991 Aug; 3(4):471-5. PubMed ID: 1684507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The complexity of structures involved in T-cell activation.
    Goodman JW; Sercarz EE
    Annu Rev Immunol; 1983; 1():465-98. PubMed ID: 6085787
    [No Abstract]   [Full Text] [Related]  

  • 59. Role of antigen-presenting cells in cross-priming of cytotoxic T lymphocytes by apoptotic cells.
    Ronchetti A; Iezzi G; Crosti MC; Garancini MP; Protti MP; Bellone M
    J Leukoc Biol; 1999 Aug; 66(2):247-51. PubMed ID: 10449162
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The cow, the boy and the lymph node--immunological principles for vaccines].
    Munthe LA
    Tidsskr Nor Laegeforen; 2006 Oct; 126(19):2532-7. PubMed ID: 17028635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.